Skip to main content
. 2020 Jul 24;16(7):e1008681. doi: 10.1371/journal.ppat.1008681

Table 2. HLA types and super-types for paired lesion and control.

Sample ID A1 A2 B1 B2 C1 C2
Healthy skin donors 3212N A*30:02 A*68:02 B*42:01 B*15:10 C*07:04 C*17:01
3214N A*30:02 A*24:02 B*50:01 B*53:01 C*06:02 C*04:01
3215N A*30:04 A*74:01 B*15:03 B*58:02 C*06:02 C*02:10
Endemic EnKS
HIV-1-
3111C_3111L A*43:01 A*68:02 B*07:02 B*58:02 C*06:02 C*07:02
3124C_3124L A*30:02 A*36:01 B*57:03 B*53:01 C*18:01 C*04:04
3135C_3135L A*30:02 A*29:02 B*45:01 B*14:03 C*06:02 C*08:02
3136C_3136L A*01:01 A*68:02 B*48:01 B*07:02 C*18:01 C*07:02
3139C_3139L A*02:01 A*23:01 B*51:01 B*15:17 C*16:01 C*05:01
3140C_3140L A*02:01 A*29:10 B*42:01 B*58:02 C*17:01 C*06:02
Epidemic EpKS
HIV-1+
3122C_3122L A*33:03 A*68:02 B*45:01 B*53:01 C*04:01 C*06:02
3128C_3128L A*02:01 A*29:02 B*13:02 B*15:03 C*02:10 C*06:02
3129C_3129L A*23:01 A*23:01 B*58:01 B*44:03 C*07:01 C*04:01
21196C_21196L A*30:02 A*68:01 B*53:08 B*58:02 C*04:01 C*06:02
21199C_21199L A*02:02 A*23:01 B*08:01 B*58:01 C*07:01 C*06:02
21221C_21221L A*23:01 A*23:01 B*15:03 B*35:01 C*04:01 C*02:10
032C_032L A*23:01 A*68:02 B*81:01 B*44:03 C*04:14 C*06:06
3022C_3022L A*02:01 A*23:01 B*49:01 B*53:01 C*07:01 C*06:02
3032C_3032L A*01:01 A*23:01 B*81:01 B*08:01 C*18:01 C*03:04
21083C_21083L A*02:01 A*68:02 B*45:01 B*53:01 C*16:01 C*04:01
023C_023L A*33:01 A*66:01 B*58:06 B*53:01 C*04:01 C*06:02
025C_025L A*23:01 A*66:01 B*42:01 B*58:02 C*17:01 C*06:02
035C_035L A*24:02 A*30:01 B*42:01 B*44:03 C*17:01 C*04:01
026C_026L A*03:01 A*30:02 B*45:01 B*58:02 C*16:01 C*06:02
034C_034L A*30:02 A*68:02 B*07:02 B*18:01 C*07:04 C*07:02
038C_038L A*02:01 A*26:01 B*07:02 B*53:01 C*04:01 C*07:02
037C_037L A*34:02 A*74:01 B*44:03 B*58:02 C*04:01 C*06:02
21214C_21214L A*02:01 A*30:02 B*14:02 B*58:02 C*06:02 C*08:02

L- Lesion

C–Control

N–Normal/Healthy

EnKS–Endemic KS

EpKS–Epidemic KS